Wall Street Analysts Predict a 36.09% Upside in Castle Biosciences (CSTL): Here's What You Should Know

Castle Biosciences, Inc. (CSTL) closed the last trading session at $24.41, gaining 17% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 33.22 indicates a 36.1% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $4.68. While the lowest estimate of$ 25 indicates a 2.4% increase from the current price level, the most optimistic anal ...